Clinical trial
Clinical Study Evaluating Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin
NCT07349459 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study Evaluating Cardioprotective Effect of Melatonin Versus Vitamin D in Breast Cancer Patients Receiving Doxorubicin
- Lead sponsor
- Tanta University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2026
- Completion date
- August 30, 2026
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer patients diagnosed, doxorubicin, melatonin, vitamin d concentration